The Immunotargeting Approach for a Vaccine against SARS-CoV-2
Audrey Kassardjian
(Julien Lab)
_____
Innate immune cell-tissue crosstalk at barrier surfaces
Louis Ngai
(Mortha Lab)
via Zoom
